Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7T72

Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAUSTRALIAN SYNCHROTRON BEAMLINE MX2
Synchrotron siteAustralian Synchrotron
BeamlineMX2
Temperature [K]100
Detector technologyPIXEL
Collection date2021-07-21
DetectorDECTRIS EIGER X 16M
Wavelength(s)0.9536
Spacegroup nameP 32 2 1
Unit cell lengths111.294, 111.294, 112.861
Unit cell angles90.00, 90.00, 120.00
Refinement procedure
Resolution48.698 - 3.177
R-factor0.2406
Rwork0.237
R-free0.30840
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)generic Fab and RBD
RMSD bond length0.003
RMSD bond angle0.809
Data reduction softwareXDS
Data scaling softwareAimless (0.7.4)
Phasing softwarePHASER (2.8.3)
Refinement softwarePHENIX (1.11.1)
Data quality characteristics
 OverallInner shellOuter shell
Low resolution limit [Å]49.91049.9103.400
High resolution limit [Å]3.1778.9903.180
Rmerge0.0790.0351.137
Rmeas0.0810.0371.173
Rpim0.0200.0100.283
Total number of observations1001040055
Number of reflections139656882418
<I/σ(I)>21.466.32.9
Completeness [%]99.399.396.5
Redundancy16.814.516.6
CC(1/2)0.9980.9980.866
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP293Equal volumes (2 uL) of protein solution (~5 mg/ml in 25 mM Tris (pH 8.0), 200 mM NaCl) and well solution (100 mM citrate (pH 4.25), 500 mM LiCl, 13% (w/v) PEG6000) were combined

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon